Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells

22 Feb 2005

Abstract excerpt

Platinum-based chemotherapeutic regimens are ultimately unsuccessful due to intrinsic or acquired drug resistance. Understanding the molecular basis for platinum drug sensitivity/resistance is necessary for the development of new drugs and therapeutic regimens. In an effort to identify such determinants, we evaluated the expression of approximately 4000 genes using cDNA microarray screening in a panel of 14...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytokine Signaling Pathways and Interactions
Share to MicroRNA in disease regulation
Share to RNA Research and Splicing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 15726096
DOI: 10.1038/sj.bjc.6602447

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cellsPMID 15726096Read ↗

Microarray-based detection and expression analysis of new genes associated with drug resistance in ovarian cancer cell linesSemantic proximity Read ↗

Molecular profiling of platinum resistant ovarian cancerSemantic proximity Read ↗

Ankyrin Repeat Domain 1, ANKRD1, a Novel Determinant of Cisplatin Sensitivity Expressed in Ovarian CancerSemantic proximity Read ↗

Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780Semantic proximity Read ↗

Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancerSemantic proximity Read ↗

Gene expression and pathway analysis of ovarian cancer cells selected for resistance to cisplatin, paclitaxel, or doxorubicinSemantic proximity Read ↗

Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrationsSemantic proximity Read ↗

miR-634 restores drug sensitivity in resistant ovarian cancer cells by targeting the Ras-MAPK pathwaySemantic proximity Read ↗

A systematic review of genes involved in the inverse resistance relationship between cisplatin and paclitaxel chemotherapy: role of BRCA1.Semantic proximity Read ↗

CD109 Promotes Drug Resistance in A2780 Ovarian Cancer Cells by Regulating the STAT3-NOTCH1 Signaling AxisSemantic proximity Read ↗

Increased Expression of Dihydrodiol Dehydrogenase Induces Resistance to Cisplatin in Human Ovarian Carcinoma CellsSemantic proximity Read ↗

Metallothionein gene expression and resistance to cisplatin in human ovarian cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.